EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H25N5O4 |
| Net Charge | 0 |
| Average Mass | 459.506 |
| Monoisotopic Mass | 459.19065 |
| SMILES | COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1 |
| InChI | InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32) |
| InChIKey | QNZCBYKSOIHPEH-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | antiviral agent A substance that destroys or inhibits replication of viruses. EC 3.4.21.6 (coagulation factor Xa) inhibitor An EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the action of coagulation factor Xa (EC 3.4.21.6). |
| Applications: | anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. anticoagulant An agent that prevents blood clotting. hepatoprotective agent Any compound that is able to prevent damage to the liver. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| apixaban (CHEBI:72296) has role anti-anaemic agent (CHEBI:75835) |
| apixaban (CHEBI:72296) has role anti-arrhythmia drug (CHEBI:38070) |
| apixaban (CHEBI:72296) has role anticoagulant (CHEBI:50249) |
| apixaban (CHEBI:72296) has role antineoplastic agent (CHEBI:35610) |
| apixaban (CHEBI:72296) has role antiviral agent (CHEBI:22587) |
| apixaban (CHEBI:72296) has role cardiovascular drug (CHEBI:35554) |
| apixaban (CHEBI:72296) has role EC 3.4.21.6 (coagulation factor Xa) inhibitor (CHEBI:68581) |
| apixaban (CHEBI:72296) has role hepatoprotective agent (CHEBI:62868) |
| apixaban (CHEBI:72296) is a aromatic ether (CHEBI:35618) |
| apixaban (CHEBI:72296) is a lactam (CHEBI:24995) |
| apixaban (CHEBI:72296) is a piperidones (CHEBI:48589) |
| apixaban (CHEBI:72296) is a pyrazolopyridine (CHEBI:46699) |
| IUPAC Name |
|---|
| 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
| INNs | Source |
|---|---|
| apixaban | KEGG DRUG |
| apixaban | WHO MedNet |
| apixabán | WHO MedNet |
| apixabanum | WHO MedNet |
| Synonyms | Source |
|---|---|
| BMS-562247 | DrugBank |
| BMS 562247-01 | ChemIDplus |
| BMS-562247-01 | ChemIDplus |
| Brand Names | Source |
|---|---|
| Apixaban accord | ChEMBL |
| Eliquis | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| Apixaban | Wikipedia |
| D03213 | KEGG DRUG |
| DB06605 | DrugBank |
| GG2 | PDBeChem |
| US2007259913 | Patent |
| WO2007022165 | Patent |
| WO2008031782 | Patent |
| WO2010030983 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:11244786 | Reaxys |
| CAS:503612-47-3 | KEGG DRUG |
| CAS:503612-47-3 | ChemIDplus |
| Citations |
|---|